Klotho Neurosciences today announced it has signed a nonbinding Letter of Intent to acquire select assets from Turn Biotechnologies, in a transaction anchored by a $300 million global pharma deal, according to the company. Under the proposed deal, Klotho would obtain Turn’s ERA (Epigenetic Reprogram…

Evelyne Bischof on cognition, biomarkers and the evolving science of keeping our brains younger for longer. As our bodies age, so do our brains – but the pace and pattern are far from predetermined. At this year’s Global Longevity Summit (28–30 October 2025, Geneva), leading experts will gather unde…

The DripBar, an intravenous vitamin therapy franchise, will launch a new location in Georgetown, D.C., on October 11, 2025. According to the company, this will become its latest facility in a network that already operates over 80 locations nationwide, with more than 600 in development. The Georgetow…

At LIC 2025, investors, scientists and founders explored how AI, equity and collaboration are shaping the next phase of healthspan innovation. The alpine calm of Gstaad belied the intensity of conversation within Le Grand Bellevue, where the sixth Longevity Investors Conference (LIC) gathered an inv…

Manjit Sareen reflects on the first Asia-Pacific Longevity Medicine International Summit and the launch of a global directory for clinics. There was a palpable sense of optimism in Hong Kong as experts from around the world gathered for the region’s first Longevity Medicine International Summit – a …